In this study, DDH-1 administration also considerably diminished the Th2-associated chemokine expression (like CCL17 and CCL22 levels), conveying the idea that ASC may be used in AD treatment for reducing the doses and adverse effects of corticosteroids and also as a monotherapy for AD prevention [62]. The gene discussed is CCL17; the disease is Alzheimer disease.